Data as of Aug 29
| +0.21 / +1.63%|
The 8 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 25.00 and a low estimate of 16.00. The median estimate represents a +37.51% increase from the last price of 13.09.
The current consensus among 9 polled investment analysts is to Buy stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.